Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
Clinical trial NCT04323631 · WITHDRAWN
Trial details
- NCT number
- NCT04323631
- Sponsor
- Rambam Health Care Campus
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2020-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.